Clinical significance of Fas antigen expression in gastric carcinoma

World Journal of Gastroenterology

Volumn 5, Issue 1, 1999, Pages 90-91

  Liu, Hai Feng ^a   Liu, Wei Wen ^a   Fang, Dian Chun ^a   Liu, Feng Xian ^a   He, Guang You ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fas antigen; Immunohistochemistry; Lymphatic metastasis; Prognosis; Stomach neoplasms pathology

Indexed keywords

EID: 0003117190     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v5.i1.90     Document Type: Article

References (4)

1. Nagata S, Goldstein P. The Fas death factor. Science, 1995;267:1449-1456
2. Higaki K, Yano H, Kojiro M. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol, 1996;149:429-437
3. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest, 1993;69:415-429
4. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 1994;263: 1759-1762